Case-Control study of Hiv Seroconversion in Health-Care Workers after Percutaneous Exposure to Hiv-Infected Blood-france,United Kingdom,and United States,January 1988-August 1994

Tokars JI , Marcus R , Culver DH , et al. Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. Ann Intern Med 1993;118:913–9.

Henderson DK . HIV-1 in the health care setting. In: Principles and practice of infectious diseases. 4th ed. Mandel GL , Bennett JE , Dolan R , editors. New York: Churchill Livingstone, 1995:2632–56.

Ho DD , Mougíl T , Alam M. Quantitation of HIV type I in the blood of infected persons. N Engl J Med 1989;321:1621–5.

Richman DD , Bozzette S. The impact of syncytium-inducing phenotype of human immuno-deficiency virus on disease progression. J Infect Dis 1994;169:968–74.

Gerberding JL . Management of occupational exposures to blood-borne viruses. N Engl J Med 1995;332:444–51.

CDC. Recommendations of the U.S. Public Health Service task force on the use of zidovudine to reduce perinatal transmission of HIV. MMWR 1994;43(no. RR-11):1–20.

Ho DD . Time to hit HIV, early and hard [Editorial]. N Engl J Med 1995;333:450–1.

Puro V , Ippolito G , Guzzanti E , et al. Zidovudine prophylaxis after accidental exposure to HIV: the Italian experience. AIDS 1992;6:963–9.

CDC. Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use. MMWR 1990;39(no. RR-1):1.